Peptide CDMO Market Size (USD 16.74 Bn) by 2032 By Types (LPPS, SPPS, Mixed Phase), By Applications Covered (Pharmaceutical Industry, Cosmetics Industry, Others) and Regional Forecast to 2032

Detailed TOC of Global Peptide CDMO Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2031

Table of Content

1 Peptide CDMO Market Overview
1.1 Product Overview and Scope of Peptide CDMO Market
1.2 Peptide CDMO Market Segment by Type
1.2.1 Global Peptide CDMO Market Sales Volume and CAGR (%) Comparison by Type (2017-2031)
1.3 Global Peptide CDMO Market Segment by Application
1.3.1 Peptide CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2031)
1.4 Global Peptide CDMO Market, Region Wise (2017-2031)
1.4.1 Global Peptide CDMO Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2031)
1.4.2 United States Peptide CDMO Market Status and Prospect (2017-2031)
1.4.3 Europe Peptide CDMO Market Status and Prospect (2017-2031)
1.4.4 China Peptide CDMO Market Status and Prospect (2017-2031)
1.4.5 Japan Peptide CDMO Market Status and Prospect (2017-2031)
1.4.6 India Peptide CDMO Market Status and Prospect (2017-2031)
1.4.7 Southeast Asia Peptide CDMO Market Status and Prospect (2017-2031)
1.4.8 Latin America Peptide CDMO Market Status and Prospect (2017-2031)
1.4.9 Middle East and Africa Peptide CDMO Market Status and Prospect (2017-2031)
1.5 Global Market Size of Peptide CDMO (2017-2031)
1.5.1 Global Peptide CDMO Market Revenue Status and Outlook (2017-2031)
1.5.2 Global Peptide CDMO Market Sales Volume Status and Outlook (2017-2031)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Peptide CDMO Market

2 Industry Outlook
2.1 Peptide CDMO Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Peptide CDMO Market Drivers Analysis
2.4 Peptide CDMO Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Peptide CDMO Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Peptide CDMO Industry Development

3 Global Peptide CDMO Market Landscape by Player
3.1 Global Peptide CDMO Sales Volume and Share by Player (2017-2022)
3.2 Global Peptide CDMO Revenue and Market Share by Player (2017-2022)
3.3 Global Peptide CDMO Average Price by Player (2017-2022)
3.4 Global Peptide CDMO Gross Margin by Player (2017-2022)
3.5 Peptide CDMO Market Competitive Situation and Trends
3.5.1 Peptide CDMO Market Concentration Rate
3.5.2 Peptide CDMO Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion

4 Global Peptide CDMO Sales Volume and Revenue Region Wise (2017-2022)
4.1 Global Peptide CDMO Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Peptide CDMO Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Peptide CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Peptide CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Peptide CDMO Market Under COVID-19
4.5 Europe Peptide CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Peptide CDMO Market Under COVID-19
4.6 China Peptide CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Peptide CDMO Market Under COVID-19
4.7 Japan Peptide CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Peptide CDMO Market Under COVID-19
4.8 India Peptide CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Peptide CDMO Market Under COVID-19
4.9 Southeast Asia Peptide CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Peptide CDMO Market Under COVID-19
4.10 Latin America Peptide CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Peptide CDMO Market Under COVID-19
4.11 Middle East and Africa Peptide CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Peptide CDMO Market Under COVID-19

5 Global Peptide CDMO Sales Volume, Revenue, Price Trend by Type
5.1 Global Peptide CDMO Sales Volume and Market Share by Type (2017-2022)
5.2 Global Peptide CDMO Revenue and Market Share by Type (2017-2022)
5.3 Global Peptide CDMO Price by Type (2017-2022)
5.4 Global Peptide CDMO Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Peptide CDMO Sales Volume, Revenue and Growth Rate of LPPS (2017-2022)
5.4.2 Global Peptide CDMO Sales Volume, Revenue and Growth Rate of SPPS (2017-2022)
5.4.3 Global Peptide CDMO Sales Volume, Revenue and Growth Rate of Mixed Phase (2017-2022)

6 Global Peptide CDMO Market Analysis by Application
6.1 Global Peptide CDMO Consumption and Market Share by Application (2017-2022)
6.2 Global Peptide CDMO Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Peptide CDMO Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Peptide CDMO Consumption and Growth Rate of Pharmaceutical Industry (2017-2022)
6.3.2 Global Peptide CDMO Consumption and Growth Rate of Cosmetics Industry (2017-2022)
6.3.3 Global Peptide CDMO Consumption and Growth Rate of Others (2017-2022)

7 Global Peptide CDMO Market Forecast (2022-2031)
7.1 Global Peptide CDMO Sales Volume, Revenue Forecast (2022-2031)
7.1.1 Global Peptide CDMO Sales Volume and Growth Rate Forecast (2022-2031)
7.1.2 Global Peptide CDMO Revenue and Growth Rate Forecast (2022-2031)
7.1.3 Global Peptide CDMO Price and Trend Forecast (2022-2031)
7.2 Global Peptide CDMO Sales Volume and Revenue Forecast, Region Wise (2022-2031)
7.2.1 United States Peptide CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.2 Europe Peptide CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.3 China Peptide CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.4 Japan Peptide CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.5 India Peptide CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.6 Southeast Asia Peptide CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.7 Latin America Peptide CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.8 Middle East and Africa Peptide CDMO Sales Volume and Revenue Forecast (2022-2031)
7.3 Global Peptide CDMO Sales Volume, Revenue and Price Forecast by Type (2022-2031)
7.3.1 Global Peptide CDMO Revenue and Growth Rate of LPPS (2022-2031)
7.3.2 Global Peptide CDMO Revenue and Growth Rate of SPPS (2022-2031)
7.3.3 Global Peptide CDMO Revenue and Growth Rate of Mixed Phase (2022-2031)
7.4 Global Peptide CDMO Consumption Forecast by Application (2022-2031)
7.4.1 Global Peptide CDMO Consumption Value and Growth Rate of Pharmaceutical Industry(2022-2031)
7.4.2 Global Peptide CDMO Consumption Value and Growth Rate of Cosmetics Industry(2022-2031)
7.4.3 Global Peptide CDMO Consumption Value and Growth Rate of Others(2022-2031)
7.5 Peptide CDMO Market Forecast Under COVID-19

8 Peptide CDMO Market Upstream and Downstream Analysis
8.1 Peptide CDMO Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Peptide CDMO Analysis
8.6 Major Downstream Buyers of Peptide CDMO Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Peptide CDMO Industry

9 Players Profiles
9.1 Chengdu Shengnuo Biotechnology Co., Ltd
9.1.1 Chengdu Shengnuo Biotechnology Co., Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Peptide CDMO Product Profiles, Application and Specification
9.1.3 Chengdu Shengnuo Biotechnology Co., Ltd Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd
9.2.1 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Peptide CDMO Product Profiles, Application and Specification
9.2.3 Jiangsu Nuotai Ao Nuo Biopharmaceutical Co., Ltd Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 PolyPeptide
9.3.1 PolyPeptide Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Peptide CDMO Product Profiles, Application and Specification
9.3.3 PolyPeptide Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Thermo Fisher Pharma
9.4.1 Thermo Fisher Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Peptide CDMO Product Profiles, Application and Specification
9.4.3 Thermo Fisher Pharma Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biopeptek
9.5.1 Biopeptek Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Peptide CDMO Product Profiles, Application and Specification
9.5.3 Biopeptek Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Alabiochem
9.6.1 Alabiochem Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Peptide CDMO Product Profiles, Application and Specification
9.6.3 Alabiochem Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 ScinoPharm
9.7.1 ScinoPharm Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Peptide CDMO Product Profiles, Application and Specification
9.7.3 ScinoPharm Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 CordenPharma
9.8.1 CordenPharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Peptide CDMO Product Profiles, Application and Specification
9.8.3 CordenPharma Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Piramal Pharma
9.9.1 Piramal Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Peptide CDMO Product Profiles, Application and Specification
9.9.3 Piramal Pharma Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Space Peptides
9.10.1 Space Peptides Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Peptide CDMO Product Profiles, Application and Specification
9.10.3 Space Peptides Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Bachem
9.11.1 Bachem Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Peptide CDMO Product Profiles, Application and Specification
9.11.3 Bachem Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Provepharm
9.12.1 Provepharm Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Peptide CDMO Product Profiles, Application and Specification
9.12.3 Provepharm Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 CPC SCIENTIFIC
9.13.1 CPC SCIENTIFIC Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Peptide CDMO Product Profiles, Application and Specification
9.13.3 CPC SCIENTIFIC Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 CBL
9.14.1 CBL Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Peptide CDMO Product Profiles, Application and Specification
9.14.3 CBL Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Alpha Biophama
9.15.1 Alpha Biophama Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Peptide CDMO Product Profiles, Application and Specification
9.15.3 Alpha Biophama Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 AmbioPharm
9.16.1 AmbioPharm Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Peptide CDMO Product Profiles, Application and Specification
9.16.3 AmbioPharm Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Aurigene Pharmaceutical Services
9.17.1 Aurigene Pharmaceutical Services Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Peptide CDMO Product Profiles, Application and Specification
9.17.3 Aurigene Pharmaceutical Services Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source